Home
NARI
NARI News

Latest Inari Medical Inc. (NARI) News on February 5, 2025

Reasons to Retain Inari Medical Stock in Your Portfolio for Now

Zacks

6 hours ago

Reasons to Retain Inari Medical Stock in Your Portfolio for Now

Thomson Reuters StreetEvents

7 days ago

Q4 2024 Stryker Corp Earnings Call

Argus Research

8 days ago

NARI: What does Argus have to say about NARI?

Is Inari Medical, Inc. (NARI) the Hottest Smid-Cap Stock So Far In 2025?

Insider Monkey

14 days ago

Is Inari Medical, Inc. (NARI) the Hottest Smid-Cap Stock So Far In 2025?

Argus Research

15 days ago

NARI: Raising target price to $72.00

Why Is Inari Medical, Inc. (NARI) Among the Hottest Mid-Cap Stocks So Far in 2025?

Insider Monkey

17 days ago

Why Is Inari Medical, Inc. (NARI) Among the Hottest Mid-Cap Stocks So Far in 2025?

Here’s Why Inari Medical, Inc. (NARI) Is Skyrocketing

Insider Monkey

19 days ago

Here’s Why Inari Medical, Inc. (NARI) Is Skyrocketing

Are You Looking for a Top Momentum Pick? Why Inari Medical, Inc. (NARI) is a Great Choice

Zacks

20 days ago

Are You Looking for a Top Momentum Pick? Why Inari Medical, Inc. (NARI) is a Great Choice

Argus Research

22 days ago

NARI: Lowering target price to $71.00

Here’s Why Inari Medical Inc. (NARI) Led This Week’s Rally

Insider Monkey

24 days ago

Here’s Why Inari Medical Inc. (NARI) Led This Week’s Rally

Is Inari Medical Inc. (NARI) Firm Posts Strong Gain Amid Wall Street Bloodbath?

Insider Monkey

a month ago

Is Inari Medical Inc. (NARI) Firm Posts Strong Gain Amid Wall Street Bloodbath?

MT Newswires

a month ago

BTIG Downgrades Inari Medical to Neutral From Buy

These Stocks Moved the Most Today: Nvidia, Micron, Aurora Innovation, Tesla, Carvana, Moderna, Palantir, and More

Barrons.com

a month ago

These Stocks Moved the Most Today: Nvidia, Micron, Aurora Innovation, Tesla, Carvana, Moderna, Palantir, and More

Inari Medical Catapults — Again — After Stryker Confirms $4.9 Billion Deal

Investor's Business Daily

a month ago

Inari Medical Catapults — Again — After Stryker Confirms $4.9 Billion Deal

MT Newswires

a month ago

Sector Update: Health Care

Stryker's $4.9B Power Move: Why This MedTech Giant Just Changed the Game

GuruFocus.com

a month ago

Stryker's $4.9B Power Move: Why This MedTech Giant Just Changed the Game

Stryker Stock Falls Despite the Agreement to Acquire Inari Medical

Zacks

a month ago

Stryker Stock Falls Despite the Agreement to Acquire Inari Medical

MT Newswires

a month ago

Jefferies Downgrades Inari Medical to Hold From Buy, $80 Price Target

Inari Medical Jumps 22% as Stryker Confirms $4.9B Acquisition Deal with 60% Premium

GuruFocus.com

a month ago

Inari Medical Jumps 22% as Stryker Confirms $4.9B Acquisition Deal with 60% Premium

MT Newswires

a month ago

Sector Update: Health Care Stocks Mixed Premarket Tuesday

These Stocks Are Moving the Most Today: Nvidia, Micron, Uber, Aurora Innovation, Carvana, Moderna, Getty Images, and More

Barrons.com

a month ago

These Stocks Are Moving the Most Today: Nvidia, Micron, Uber, Aurora Innovation, Carvana, Moderna, Getty Images, and More

MT Newswires

a month ago

Canaccord Genuity Downgrades Inari Medical to Hold From Buy, Adjusts Price Target to $80 From $74

MT Newswires

a month ago

Baird Downgrades Inari Medical to Neutral From Outperform, Trims Price Target to $80 From $81

MT Newswires

a month ago

William Blair Downgrades Inari Medical to Market Perform From Outperform

5 Things to Know Before the Stock Market Opens

Investopedia

a month ago

5 Things to Know Before the Stock Market Opens

MT Newswires

a month ago

Deutsche Bank Downgrades Inari Medical to Hold From Buy, Raises Price Target to $80 From $68

Inari Shares Skyrocket As Stryker Will Acquire Medical Device Maker for $4.9B

Investopedia

a month ago

Inari Shares Skyrocket As Stryker Will Acquire Medical Device Maker for $4.9B

Reasons to Retain Inari Medical Stock in Your Portfolio for Now

Zacks

a month ago

Reasons to Retain Inari Medical Stock in Your Portfolio for Now

Inari Medical to Present at the J.P. Morgan Healthcare Conference

GlobeNewswire

a month ago

Inari Medical to Present at the J.P. Morgan Healthcare Conference

Argus Research

a month ago

NARI: Lowering target price to $43.00

Inari Medical price target raised to $63 from $50 at Truist

TipRanks

2 months ago

Inari Medical price target raised to $63 from $50 at Truist

MT Newswires

2 months ago

Inari Medical Insider Sold Shares Worth $3,339,704, According to a Recent SEC Filing

MT Newswires

2 months ago

Truist Securities Raises Price Target on Inari Medical to $63 From $50, Keeps Hold Rating

Argus Research

2 months ago

NARI: Raising target price to $45.00

MT Newswires

2 months ago

Oppenheimer Initiates Coverage on Inari Medical With Outperform Rating, $75 Price Target

Inari Medical Stock Gets RS Rating Upgrade

Investor's Business Daily

2 months ago

Inari Medical Stock Gets RS Rating Upgrade

Argus Research

2 months ago

NARI: Raising target price to $44.00

Hologic (HOLX) Down 1.7% Since Last Earnings Report: Can It Rebound?

Zacks

2 months ago

Hologic (HOLX) Down 1.7% Since Last Earnings Report: Can It Rebound?

Reasons to Retain Inari Medical Stock in Your Portfolio for Now

Zacks

2 months ago

Reasons to Retain Inari Medical Stock in Your Portfolio for Now

Argus Research

2 months ago

NARI: What does Argus have to say about NARI?

NARI Stock Likely to Gain Following Reimbursement Approval in Japan

Zacks

2 months ago

NARI Stock Likely to Gain Following Reimbursement Approval in Japan

Inari Medical enters China distribution partnership

Medical Device Network

2 months ago

Inari Medical enters China distribution partnership

MT Newswires

2 months ago

Inari Medical Forms Joint Venture in Greater China

Inari Medical Announces Reimbursement Approval for ClotTriever® Thrombectomy System in Japan and New Distribution Partnership with Medikit Co., Ltd.

GlobeNewswire

2 months ago

Inari Medical Announces Reimbursement Approval for ClotTriever® Thrombectomy System in Japan and New Distribution Partnership with Medikit Co., Ltd.

Inari Medical Announces Joint Venture in Greater China

GlobeNewswire

2 months ago

Inari Medical Announces Joint Venture in Greater China

Why Is Penumbra (PEN) Up 6.7% Since Last Earnings Report?

Zacks

2 months ago

Why Is Penumbra (PEN) Up 6.7% Since Last Earnings Report?

Argus Research

2 months ago

NARI: What does Argus have to say about NARI?

MT Newswires

3 months ago

Inari Medical Insider Sold Shares Worth $3,069,521, According to a Recent SEC Filing

Inside a $400 billion bet on the brain-computer interface revolution

Yahoo Finance

3 months ago

Inside a $400 billion bet on the brain-computer interface revolution

Argus Research

3 months ago

NARI: Raising target price to $41.00

Is Inari Medical (NARI) Trading at an Attractive Valuation?

Insider Monkey

3 months ago

Is Inari Medical (NARI) Trading at an Attractive Valuation?

Inari Medical to Participate in the Jefferies London Healthcare Conference

GlobeNewswire

3 months ago

Inari Medical to Participate in the Jefferies London Healthcare Conference

Argus Research

3 months ago

NARI: Raising target price to $40.00

MT Newswires

3 months ago

Inari Medical Insider Sold Shares Worth $2,002,000, According to a Recent SEC Filing

Edwards, Medtronic and Inari share trial data at TCT conference

MedTech Dive

3 months ago

Edwards, Medtronic and Inari share trial data at TCT conference

Inari Medical Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

Simply Wall St.

3 months ago

Inari Medical Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

Inari Medical Inc (NARI) Q3 2024 Earnings Call Highlights: Record Revenue and Raised Guidance ...

GuruFocus.com

3 months ago

Inari Medical Inc (NARI) Q3 2024 Earnings Call Highlights: Record Revenue and Raised Guidance ...

MT Newswires

3 months ago

Inari Medical's FlowTriever Outperforms Catheter-Directed Thrombolytics in Pulmonary Embolism Treatment; Shares Up

PEERLESS Results Show Superiority of FlowTriever® Compared to Catheter-Directed Thrombolytics for Intermediate-Risk Pulmonary Embolism

GlobeNewswire

3 months ago

PEERLESS Results Show Superiority of FlowTriever® Compared to Catheter-Directed Thrombolytics for Intermediate-Risk Pulmonary Embolism

Inari Medical Q3 Earnings Miss Estimates, Revenues Increase Y/Y

Zacks

3 months ago

Inari Medical Q3 Earnings Miss Estimates, Revenues Increase Y/Y

MT Newswires

3 months ago

Truist Raises Price Target on Inari Medical to $50 From $46, Keeps Hold Rating

Inari Medical, Inc. (NARI) Reports Q3 Loss, Tops Revenue Estimates

Zacks

3 months ago

Inari Medical, Inc. (NARI) Reports Q3 Loss, Tops Revenue Estimates

MT Newswires

3 months ago

Inari Medical Reports Q3 Loss, Higher Revenue; 2024 Sales Midpoint Guidance Boosted; Shares Rise

Inari Medical Reports Third Quarter 2024 Financial Results

GlobeNewswire

3 months ago

Inari Medical Reports Third Quarter 2024 Financial Results

Penumbra (PEN) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Zacks

3 months ago

Penumbra (PEN) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Okami Medical Announces Closing Of $32.5M Financing

PR Newswire

3 months ago

Okami Medical Announces Closing Of $32.5M Financing

Analysts Estimate Inari Medical, Inc. (NARI) to Report a Decline in Earnings: What to Look Out for

Zacks

3 months ago

Analysts Estimate Inari Medical, Inc. (NARI) to Report a Decline in Earnings: What to Look Out for

Inari Medical Announces Partnership with AVF and NBCA on DEFIANCE Trial

GlobeNewswire

4 months ago

Inari Medical Announces Partnership with AVF and NBCA on DEFIANCE Trial

Inari Medical Inc (NARI) Q2 2024 Earnings Call Highlights: Record Revenue Growth Amidst Challenges

GuruFocus.com

4 months ago

Inari Medical Inc (NARI) Q2 2024 Earnings Call Highlights: Record Revenue Growth Amidst Challenges

Argus Research

4 months ago

NARI: Raising target price to $34.00

Inari Medical to Host Analyst and Investor Meeting Following PEERLESS RCT Presentation

GlobeNewswire

4 months ago

Inari Medical to Host Analyst and Investor Meeting Following PEERLESS RCT Presentation

Inari Medical to Announce Third Quarter 2024 Financial Results

GlobeNewswire

4 months ago

Inari Medical to Announce Third Quarter 2024 Financial Results

MT Newswires

5 months ago

Stifel Initiates Inari Medical at Hold With $50 Price Target

Reasons to Retain Inari Medical Stock in Your Portfolio for Now

Zacks

5 months ago

Reasons to Retain Inari Medical Stock in Your Portfolio for Now

MT Newswires

5 months ago

Leerink Partners Initiates Inari Medical at Market Perform

Inari Medical Announces PEERLESS Data to be Presented During the Late-Breaking Clinical Trial Sessions at TCT 2024

GlobeNewswire

5 months ago

Inari Medical Announces PEERLESS Data to be Presented During the Late-Breaking Clinical Trial Sessions at TCT 2024

Argus Research

5 months ago

NARI: Lowering target price to $35.00

Inari updates label of clot removal device linked to 6 deaths

MedTech Dive

5 months ago

Inari updates label of clot removal device linked to 6 deaths

FDA Classifies Recall Of Inari Medical's Large Vessel Clot Removal Catheter Device As Most Serious

Benzinga

5 months ago

FDA Classifies Recall Of Inari Medical's Large Vessel Clot Removal Catheter Device As Most Serious

Inari Medical (NARI) Issues Notice Post ClotTriever XL Recall

Zacks

5 months ago

Inari Medical (NARI) Issues Notice Post ClotTriever XL Recall

Inari Medical to Present at Upcoming Investor Conferences

GlobeNewswire

5 months ago

Inari Medical to Present at Upcoming Investor Conferences

Argus Research

6 months ago

NARI: Raising target price to $39.00

Director William Hoffman Sells 60,000 Shares of Inari Medical Inc (NARI)

GuruFocus.com

6 months ago

Director William Hoffman Sells 60,000 Shares of Inari Medical Inc (NARI)

The Inari Medical, Inc. (NASDAQ:NARI) Second-Quarter Results Are Out And Analysts Have Published New Forecasts

Simply Wall St.

6 months ago

The Inari Medical, Inc. (NASDAQ:NARI) Second-Quarter Results Are Out And Analysts Have Published New Forecasts

Inari promotes Kevin Strange to CFO

MedTech Dive

6 months ago

Inari promotes Kevin Strange to CFO

Inari Medical Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

Simply Wall St.

6 months ago

Inari Medical Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

Inari Medical (NARI) Q2 Earnings Miss, Revenues Increase Y/Y

Zacks

6 months ago

Inari Medical (NARI) Q2 Earnings Miss, Revenues Increase Y/Y

MT Newswires

6 months ago

Truist Adjusts Inari Medical's Price Target to $55 From $60, Maintains Hold Rating

MT Newswires

6 months ago

Inari Medical Q2 Swings to Loss, Raises 2024 Revenue Guidance; Appoints Kevin Strange CFO

Inari Medical, Inc. (NARI) Reports Q2 Loss, Tops Revenue Estimates

Zacks

6 months ago

Inari Medical, Inc. (NARI) Reports Q2 Loss, Tops Revenue Estimates

Inari Medical Announces Chief Financial Officer Retirement and Succession Plan

GlobeNewswire

6 months ago

Inari Medical Announces Chief Financial Officer Retirement and Succession Plan

Inari Medical Reports Second Quarter 2024 Financial Results

GlobeNewswire

6 months ago

Inari Medical Reports Second Quarter 2024 Financial Results

Is Now The Time To Look At Buying Inari Medical, Inc. (NASDAQ:NARI)?

Simply Wall St.

6 months ago

Is Now The Time To Look At Buying Inari Medical, Inc. (NASDAQ:NARI)?

MT Newswires

6 months ago

William Blair Starts Inari Medical With Outperform Rating

Glaukos (GKOS) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Zacks

6 months ago

Glaukos (GKOS) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Argus Research

6 months ago

NARI: Lowering target price to $44.00

Inari Medical, Inc. (NARI) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release

Zacks

6 months ago

Inari Medical, Inc. (NARI) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release

Insider Sale: Chief Medical Officer Thomas Tu Sells Shares of Inari Medical Inc (NARI)

GuruFocus.com

7 months ago

Insider Sale: Chief Medical Officer Thomas Tu Sells Shares of Inari Medical Inc (NARI)

Director William Hoffman Sells 60,000 Shares of Inari Medical Inc (NARI)

GuruFocus.com

7 months ago

Director William Hoffman Sells 60,000 Shares of Inari Medical Inc (NARI)

MT Newswires

7 months ago

Inari Medical Insider Sold Shares Worth $3,404,646, According to a Recent SEC Filing

Share on Social Networks: